Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of Human T-cell Leukemia Virus Antibodies among Young Females Attending a Large Medical Diagnostic Laboratory in Neyshabour, Northeast of Iran, During 2011 to 2015

Masoud Mobini 1 and Mohammad Salehi 2 , *
Authors Information
1 Young Researchers and Elite Clup, Tonekabon Branch, Islamic Azad University, Tonekabon, IR Iran
2 Blood Borne Infections Research Center, Razavi Khorasan Branch, Academic Center for Education, Culture and Research (ACECR), Mashhad, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: June 2018, 13 (3); e62305
  • Published Online: June 27, 2018
  • Article Type: Brief Report
  • Received: November 26, 2016
  • Revised: September 28, 2017
  • Accepted: February 17, 2018
  • DOI: 10.5812/archcid.62305

To Cite: Mobini M, Salehi M. Prevalence of Human T-cell Leukemia Virus Antibodies among Young Females Attending a Large Medical Diagnostic Laboratory in Neyshabour, Northeast of Iran, During 2011 to 2015, Arch Clin Infect Dis. 2018 ; 13(3):e62305. doi: 10.5812/archcid.62305.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results and Discussion
Acknowledgements
Footnote
References
  • 1. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2011;13(6):424-7. [PubMed: 22737506]. [PubMed Central: PMC3371930].
  • 2. Salehi M, Shokouhi Mostafavi SK, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 Infection in Neyshabur City, North-Eastern Iran, during 2010-2014. Iran Biomed J. 2017;21(1):57-60. [PubMed: 26899860]. [PubMed Central: PMC5141255].
  • 3. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266-81. doi: 10.1016/s1473-3099(07)70081-6.
  • 4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. doi: 10.1038/sj.onc.1208968. [PubMed: 16155612].
  • 5. Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Glob J Health Sci. 2014;6(5):99-104. doi: 10.5539/gjhs.v6n5p99. [PubMed: 25168999]. [PubMed Central: PMC4825399].
  • 6. Rafatpanah H, Fathimoghadam F, Shahabi M, Eftekharzadeh I, Hedayati-Moghaddam M, Valizadeh N, et al. No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran. Iran J Basic Med Sci. 2013;16(3):229-34. [PubMed: 24470868]. [PubMed Central: PMC3881255].
  • 7. Maghsudlu M, Safabakhsh H, Jamili P. Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar. Asian J Transfus Sci. 2015;9(2):203-6. doi: 10.4103/0973-6247.154255. [PubMed: 26420946]. [PubMed Central: PMC4562147].
  • 8. Armah HB, Narter-Olaga EG, Adjei AA, Asomaning K, Gyasi RK, Tettey Y. Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. J Med Microbiol. 2006;55(Pt 6):765-70. doi: 10.1099/jmm.0.46426-0. [PubMed: 16687597].
  • 9. Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006;78(5):683-92. doi: 10.1002/jmv.20593. [PubMed: 16555290].
  • 10. Etenna SL, Caron M, Besson G, Makuwa M, Gessain A, Mahe A, et al. New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa. J Clin Microbiol. 2008;46(11):3607-14. doi: 10.1128/JCM.01249-08. [PubMed: 18845819]. [PubMed Central: PMC2576568].
  • 11. Maloney EM, Yamano Y, Vanveldhuisen PC, Sawada T, Kim N, Cranston B, et al. Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. J Infect Dis. 2006;194(5):552-60. doi: 10.1086/506365. [PubMed: 16897651].
  • 12. Tortevoye P, Tuppin P, Carles G, Peneau C, Gessain A. Comparative trends of seroprevalence and seroincidence rates of human T cell lymphotropic virus type I and human immunodeficiency virus 1 in pregnant women of various ethnic groups sharing the same environment in French Guiana. Am J Trop Med Hyg. 2005;73(3):560-5. [PubMed: 16172481].
  • 13. Maehama T. Human T cell leukemia virus-1 in pregnancy. Int J Gynaecol Obstet. 2004;87(3):247-8. doi: 10.1016/j.ijgo.2004.07.024. [PubMed: 15548399].
  • 14. Taylor GP, Bodeus M, Courtois F, Pauli G, Del Mistro A, Machuca A, et al. The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr. 2005;38(1):104-9. [PubMed: 15608533].
  • 15. Tseliou PM, Spanakis N, Spiliotakara A, Markogiannakis A, Legakis NJ, Tsakris A. Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. Int J STD AIDS. 2006;17(8):543-6. doi: 10.1258/095646206778145541. [PubMed: 16925902].
  • 16. Ydy RR, Ferreira D, Souto FJ, Fontes CJ. [Prevalence of human T-cell lymphotropic virus (HTLV-1/2) infection among puerperae in Cuiaba, Mato Grosso, 2006]. Rev Soc Bras Med Trop. 2009;42(1):28-32. [PubMed: 19287932].
  • 17. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388. doi: 10.3389/fmicb.2012.00388. [PubMed: 23162541]. [PubMed Central: PMC3498738].
  • 18. Alarcon JO, Friedman HB, Montano SM, Zunt JR, Holmes KK, Quinnan GV Jr. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru. J Acquir Immune Defic Syndr. 2006;42(5):604-9. doi: 10.1097/01.qai.0000221680.52563.d5. [PubMed: 16773029]. [PubMed Central: PMC2683844].
  • 19. Trenchi A, Gastaldello R, Balangero M, Irizar M, Cudola A, Gallego S. Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina. J Med Virol. 2007;79(12):1974-8. doi: 10.1002/jmv.21027. [PubMed: 17935192].
  • 20. Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, et al. Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)–Infected Individuals Without HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study. Clin Infect Dis. 2015;61(1):49-56. doi: 10.1093/cid/civ229.
  • 21. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007;17(6):425-33. doi: 10.1111/j.1365-3148.2007.00794.x. [PubMed: 18067646].
  • 22. Salehi M, Mobini M. The seroepidemiological of Human T-lymphotropic virus on children, teenage and juveniles in Nyshabor city. Iran J Med Microbiol. 2015;9(3):31-5.
  • 23. Salehi M, Afrisham M. The seroepidemiological survey of HTLV1, 2 infections in Nyshabor city (Northeast of Iran). Lab Diagnos. 2014;6(23):35-8.
  • 24. Mortezaie Z, Bouzari M, Roghanian R. Evaluating the frequency of HTLV-Ι/II infection among blood donors, major thalassemic patients and individuals infected with hepatitis B and C viruses in Isfahan, Iran. Iran J Blood Cancer. 2012;4(2):75-80.
  • 25. Okoye AE, Ibegbulam OG, Onoh RC, Ezeonu PO, Ugwu NI, Lawani LO, et al. Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Int J Womens Health. 2014;6:849-55. doi: 10.2147/IJWH.S64199. [PubMed: 25258559]. [PubMed Central: PMC4174018].
  • 26. Monteiro DL, Taquette SR, Sodre Barmpas DB, Rodrigues NC, Teixeira SA, Villela LH, et al. Prevalence of HTLV-1/2 in pregnant women living in the metropolitan area of Rio de Janeiro. PLoS Negl Trop Dis. 2014;8(9). e3146. doi: 10.1371/journal.pntd.0003146. [PubMed: 25188386]. [PubMed Central: PMC4154655].
  • 27. Yamada T, Togashi T, Tsutsumi H, Imamura M, Okubo H, Okabe M, et al. Prevalence of human T‐lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan. Microbiol Immun. 2014;58(8):427-31.
  • 28. Hatami H, Karimi GH, Safabakhsh HR. Seroepidemiologic prevalence of HTLV in voluntary blood donors in Mashhad. Sci J Iran Blood Transfusion Organization. 2012;9(2).
  • 29. Karimi G, Zadsar M, Pourfathollah AA. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virol J. 2017;14(1):14. doi: 10.1186/s12985-017-0693-9. [PubMed: 28137274]. [PubMed Central: PMC5282699].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments